Hillevax Inc (HLVX)

Name: Hillevax Inc (HLVX) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Hillevax Inc (HLVX)

Stock Card

$2.09

$0.00 (0.00%)

As on 17-Sep-2025 09:30EDT

Market cap

$105 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

0.7

Div. Yield

0 %

Hillevax Inc (HLVX) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 2.09 High: 2.09

52 Week Range

Low: 1.34 High: 2.17

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.4 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-4.1
Debt to Equity

0
Book Value

$--
EPS

$-1.4
Face value

--
Shares outstanding

50,125,541

5 Years Aggregate

CFO

$-157.81 Mln

EBITDA

$-230.00 Mln

Net Profit

$-468.40 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Hillevax Inc (HLVX)	1.0	0.5	12.4	16.8	-54.2	--	--
BSE Sensex^*	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 17-Sep-2025 | *As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2024	2023
Hillevax Inc (HLVX)	-86.9	-4.1
S&P Small-Cap 600	7.0	13.9
BSE Sensex	8.1	18.7

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Hillevax Inc (HLVX)	2.1	104.8	0.0	-71.1	--	-47	--	0.7
Y-mAbs Therapeutics (YMAB)	8.6	391.2	85.4	-22.2	-24.7	-24.8	--	4.5

Shareholding Pattern

View Details

About Hillevax Inc (HLVX)

HilleVax, Inc., a clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute... gastroenteritis caused by norovirus infection. It has a license agreement with Takeda Vaccines, Inc. to develop and commercialize HIL-214 pharmaceutical products. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts. As of September 17, 2025, HilleVax, Inc. operates as a subsidiary of XOMA Royalty Corporation. Read more

President, CEO & Chairman of the Board

Dr. Robert M. Hershberg M.D., Ph.D.
President, CEO & Chairman of the Board

Dr. Robert M. Hershberg M.D., Ph.D.
Headquarters

Boston, MA
Website

https://www.hillevax.com

FAQs for Hillevax Inc (HLVX)

What is the current share price of Hillevax Inc (HLVX) Today?

The share price of Hillevax Inc (HLVX) is $2.09 (NASDAQ) as of 17-Sep-2025 09:30 EDT. Hillevax Inc (HLVX) has given a return of -54.2% in the last 3 years.

What is the current PB & PE ratio of Hillevax Inc (HLVX)?

Since, TTM earnings of Hillevax Inc (HLVX) is negative, P/E ratio is not available.
The P/B ratio of Hillevax Inc (HLVX) is 0.71 times as on 17-Sep-2025, a 87 discount to its peers’ median range of 5.35 times.

PE & PB ratio at the end of financial year.